Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information.
about
IDAAPM: integrated database of ADMET and adverse effects of predictive modeling based on FDA approved drug dataThe Human Kinome Targeted by FDA Approved Multi-Target Drugs and Combination Products: A Comparative Study from the Drug-Target Interaction Network PerspectiveExploring the Inhibitory Mechanism of Approved Selective Norepinephrine Reuptake Inhibitors and Reboxetine Enantiomers by Molecular Dynamics StudyHarnessing public domain data to discover and validate therapeutic targets.Performance Evaluation and Online Realization of Data-driven Normalization Methods Used in LC/MS based Untargeted Metabolomics Analysis.MeSHDD: Literature-based drug-drug similarity for drug repositioningNetwork pharmacology-based and clinically relevant prediction of the active ingredients and potential targets of Chinese herbs in metastatic breast cancer patients.NOREVA: normalization and evaluation of MS-based metabolomics data.SVM-Prot 2016: A Web-Server for Machine Learning Prediction of Protein Functional Families from Sequence Irrespective of Similarity.Bioinformatics tools for quantitative and functional metagenome and metatranscriptome data analysis in microbes.DrugSig: A resource for computational drug repositioning utilizing gene expression signatures.Identifying drug-pathway association pairs based on L1L2,1-integrative penalized matrix decomposition.Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndromeImprovements to PATRIC, the all-bacterial Bioinformatics Database and Analysis Resource Center.Open Targets: a platform for therapeutic target identification and validationPharos: Collating protein information to shed light on the druggable genome.Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era.PDTCM: a systems pharmacology platform of traditional Chinese medicine for psoriasis.Identifying prognostic signature in ovarian cancer using DirGenerankIn silico polypharmacology of natural products.Using reverse docking for target identification and its applications for drug discovery.Current situation and future usage of anticancer drug databases.Identifying new antiepileptic drugs through genomics-based drug repurposing.PBIT: Pipeline Builder for Identification of drug Targets for infectious diseases.Comparison of FDA Approved Kinase Targets to Clinical Trial Ones: Insights from Their System Profiles and Drug-Target Interaction Networks.NPASS: natural product activity and species source database for natural product research, discovery and tool development.PTS: a pharmaceutical target seeker.Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics.miRDDCR: a miRNA-based method to comprehensively infer drug-disease causal relationships.Drug knowledge bases and their applications in biomedical informatics research.NutriChem 2.0: exploring the effect of plant-based foods on human health and drug efficacy.Assessing the Performances of Protein Function Prediction Algorithms from the Perspectives of Identification Accuracy and False Discovery Rate.Quantitative and Systems Pharmacology. 1. In Silico Prediction of Drug-Target Interactions of Natural Products Enables New Targeted Cancer Therapy.Revealing vilazodone's binding mechanism underlying its partial agonism to the 5-HT1A receptor in the treatment of major depressive disorder.Evidence-Based Precision Oncology with the Cancer Targetome.Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes.Molecular targets of Chinese herbs: a clinical study of metastatic colorectal cancer based on network pharmacology.Systems Pharmacology Based Strategy for Q-Markers Discovery of HuangQin Decoction to Attenuate Intestinal Damage.Docking-based inverse virtual screening: methods, applications, and challenges.
P2860
Q27902312-D696DE82-6880-4C4E-A71B-61CFD7FF9749Q28553277-9F6F4C2B-CF47-412A-BD9B-3DE43F87823BQ28833274-2D07CBDE-7A90-4D15-A943-E8E34965CBA5Q30491667-3B1E71B2-05EE-4ABC-861F-2ED36617C885Q31148475-4F45E785-88C8-4D22-AA4B-97FDC0A03A8FQ33564905-801404D6-F3F2-4F34-8EDD-14CE785A51E4Q33688907-9C59B6F6-7E48-4635-B671-48BF22D2256DQ34556970-49CE5ECE-FFEB-4ABF-9E2E-146107E0E357Q36104137-7DBF9229-99A7-4A8A-A621-1AEADA6477C8Q36365823-5D636E67-96E1-4CE0-A5CC-B59B848BC50FQ36386321-6BBDC7FE-C38F-4E2C-81CD-96118177EF48Q36408203-AF4CEE44-693F-4D51-85CC-A600816A7E58Q37010566-FCDEEDBD-766E-458E-8F8D-7E59F76CB1F5Q37556690-D2375558-111D-4C20-BFE9-758C7BCF234BQ37556749-64418928-36D2-4843-8457-31B4E5901339Q37556791-4F7C4BDC-81C7-45CE-97C5-7823CC989EA8Q38379632-BA924E26-8A2B-4D51-8ECE-F2A9C3A1DC8AQ38637309-BE611B2F-C52C-481F-B3F8-61066E01D098Q38725310-6D685E0F-FBAA-4C52-BAC4-DFAAA1E08462Q38810969-1D355E6F-CBF0-4448-8B29-C2CC1DEB7F5DQ38836168-B0A63729-90AC-4733-9D4D-8F15F71C178FQ38837677-52623F1D-F75A-4E21-91AF-C96ECBFE4506Q39040011-FECB1108-A181-4542-AF8C-211F45D7F582Q39049129-7C9C1834-67E5-47AB-AD85-78CBEE5F8153Q42195551-1B5FA460-E791-43FA-9D95-21A6B7A53459Q46268156-87D85AF3-7C73-4BCA-8657-11DCE3D90489Q47095525-E5E3678D-EBCE-4E74-B8C4-DBD0B61CE2FFQ47116549-63A20A6D-B3FF-4A96-99C0-AAA0A76E0D5CQ47137904-C6DF88C5-78B7-40C4-98EC-802595445E20Q47205411-B7D3A3E2-9D9A-4969-B7B9-1AB50258776DQ47206588-A0A63075-D48A-49E6-B17F-0C29C6809B2AQ47216858-73EC118E-CBB4-4701-8C03-D108211B9026Q47731882-8A9287AA-8F15-4A93-B48A-E8E32CF479B0Q47732078-8336D3A0-B6C1-40B9-92FF-87477FA1991AQ47893147-D38F49DA-7F4D-4DE7-B90C-CE82E71AB1DCQ49315568-24EC4D73-FBAC-40F0-A5DD-988CCB5FBD78Q50531000-B18B7DC1-1264-4F29-BB05-062A08B8273CQ54957720-01FA3C9F-8DAC-42CC-999B-EBF0C5535AABQ55296424-84AE9C3A-1137-47B7-829A-EEBC5F8B2485Q55341853-1AC37436-5857-4DA1-9941-BACC100B3938
P2860
Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Therapeutic target database up ...... targeted pathway information.
@ast
Therapeutic target database up ...... targeted pathway information.
@en
type
label
Therapeutic target database up ...... targeted pathway information.
@ast
Therapeutic target database up ...... targeted pathway information.
@en
prefLabel
Therapeutic target database up ...... targeted pathway information.
@ast
Therapeutic target database up ...... targeted pathway information.
@en
P2093
P2860
P50
P356
P1476
Therapeutic target database up ...... targeted pathway information.
@en
P2093
Chun Yan Yu
P2860
P304
P356
10.1093/NAR/GKV1230
P407
P577
2015-11-17T00:00:00Z